We welcome discussion of the QUARTZ trial1 results, which demonstrated that survival and quality of life for patients with brain metastases from non-small cell lung cancer (NSCLC) were similar regardless of whether whole brain radiotherapy (WBRT) was used in addition to optimal supportive care.